{"address1": "Tuborg Boulevard 12", "city": "Hellerup", "zip": "2900", "country": "Denmark", "phone": "45 70 22 22 44", "website": "https://ascendispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It also develops a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. Ascendis Pharma A/S was incorporated in 2006 and is headquartered in Hellerup, Denmark.", "fullTimeEmployees": 1017, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jan Moller Mikkelsen", "age": 64, "title": "President, CEO, Member of Executive Board & Executive Director", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott T. Smith", "age": 50, "title": "CFO, Executive VP & Member of Executive Board", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lotte  Sonderbjerg", "age": 63, "title": "Executive VP, Chief Administrative Officer & Member of the Executive Board", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael Wolff Jensen L.L.M.", "age": 53, "title": "Executive VP, Chief Legal Officer & Member of the Executive Board", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mads  Bodenhoff", "age": 55, "title": "Senior VP, Head of Finance & Principal Accounting Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Timothy J. Lee", "title": "Senior Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Flemming Steen Jensen", "age": 63, "title": "Executive Vice President of Product Supply & Quality", "yearBorn": 1961, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kennett  Sprogoe Ph.D.", "age": 45, "title": "Executive VP and Head of Research & Product Development", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stina  Singel M.D., Ph.D.", "age": 50, "title": "Executive VP & Head of Clinical Development for Oncology", "yearBorn": 1974, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Kelly", "age": 55, "title": "Head of U.S. Commercial of Endocrinology", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 155.86, "open": 156.73, "dayLow": 148.4, "dayHigh": 158.45, "regularMarketPreviousClose": 155.86, "regularMarketOpen": 156.73, "regularMarketDayLow": 148.4, "regularMarketDayHigh": 158.45, "payoutRatio": 0.0, "beta": 0.612, "forwardPE": -38.336708, "volume": 655815, "regularMarketVolume": 655815, "averageVolume": 483071, "averageVolume10days": 365220, "averageDailyVolume10Day": 365220, "bid": 148.98, "ask": 153.27, "bidSize": 3, "askSize": 3, "marketCap": 9104683008, "fiftyTwoWeekLow": 111.09, "fiftyTwoWeekHigh": 169.37, "priceToSalesTrailing12Months": 25.03756, "fiftyDayAverage": 144.8466, "twoHundredDayAverage": 136.01022, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 9359188992, "profitMargins": -1.03972, "floatShares": 59372631, "sharesOutstanding": 60124700, "sharesShort": 4384256, "sharesShortPriorMonth": 3628368, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.073, "heldPercentInsiders": 0.00778, "heldPercentInstitutions": 1.1046801, "shortRatio": 8.89, "shortPercentOfFloat": 0.087799996, "impliedSharesOutstanding": 60124700, "bookValue": -1.766, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -378084000, "trailingEps": -7.07, "forwardEps": -3.95, "enterpriseToRevenue": 25.737, "enterpriseToEbitda": -34.179, "52WeekChange": 0.012909651, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 151.43, "targetHighPrice": 289.812, "targetLowPrice": 160.30254, "targetMeanPrice": 209.78073, "targetMedianPrice": 200.33928, "recommendationMean": 1.26667, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 15, "totalCash": 559542976, "totalCashPerShare": 9.35, "ebitda": -273828000, "totalDebt": 856616000, "quickRatio": 0.812, "currentRatio": 1.169, "totalRevenue": 363640992, "revenuePerShare": 6.281, "returnOnAssets": -0.17379, "grossProfits": 319383008, "freeCashflow": -200316880, "operatingCashflow": -306196992, "revenueGrowth": 0.263, "grossMargins": 0.87829, "ebitdaMargins": -0.75302005, "operatingMargins": 0.0022, "financialCurrency": "EUR", "symbol": "ASND", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_39510693", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743583452, "regularMarketTime": 1743537602, "regularMarketChangePercent": -2.8422995, "regularMarketPrice": 151.43, "shortName": "Ascendis Pharma A/S", "longName": "Ascendis Pharma A/S", "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422455400000, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketPrice": 151.43, "regularMarketChange": -4.430008, "regularMarketDayRange": "148.4 - 158.45", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 483071, "fiftyTwoWeekLowChange": 40.339996, "fiftyTwoWeekLowChangePercent": 0.36312896, "fiftyTwoWeekRange": "111.09 - 169.37", "fiftyTwoWeekHighChange": -17.940002, "fiftyTwoWeekHighChangePercent": -0.10592196, "fiftyTwoWeekChangePercent": 1.2909651, "earningsTimestamp": 1739394060, "earningsTimestampStart": 1746010740, "earningsTimestampEnd": 1746446400, "earningsCallTimestampStart": 1739395800, "earningsCallTimestampEnd": 1739395800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -7.07, "epsForward": -3.95, "epsCurrentYear": -3.28416, "priceEpsCurrentYear": -46.109203, "fiftyDayAverageChange": 6.5833893, "fiftyDayAverageChangePercent": 0.045450766, "twoHundredDayAverageChange": 15.419769, "twoHundredDayAverageChangePercent": 0.11337213, "priceToBook": -85.747444, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null}